Lumosa Therapeutics Co., Ltd. (TPEX:6535)
Taiwan · Delayed Price · Currency is TWD 142.50
-6.00 (-4.04%)
Apr 2, 2026, 1:30 PM CST
Lumosa Therapeutics Market Cap
Lumosa Therapeutics has a market cap or net worth of 23.87 billion as of April 2, 2026. Its market cap has decreased by -37.89% in one year.
Market Cap
23.87B
Enterprise Value
23.09B
Revenue
35.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
142.50
Market Cap Chart
Since July 16, 2015, Lumosa Therapeutics's market cap has increased from 4.29B to 23.87B, an increase of 455.70%. That is a compound annual growth rate of 17.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 23.87B | -27.16% |
| Dec 31, 2025 | 32.77B | -22.40% |
| Dec 31, 2024 | 42.22B | 274.74% |
| Dec 29, 2023 | 11.27B | 75.37% |
| Dec 30, 2022 | 6.43B | 5.04% |
| Dec 30, 2021 | 6.12B | 17.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pell Bio-Med Technology | 36.29B |
| Lin BioScience | 31.97B |
| Oneness Biotech | 26.12B |
| Sunmax Biotechnology | 20.94B |
| Medigen Vaccine Biologics | 19.33B |
| EirGenix | 17.34B |
| AP Biosciences | 17.24B |
| Polaris Group | 17.11B |